Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229 -91111. Fax: +32 229 -64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu . 
  EUROPEAN COMMISSION  
Brussels, 5.12.2022  
C(2022 ) 9151 final  
PUBLIC VERSION  
Kirk Kapital Strategic Investments A/S  
Havneøen 1  
DK-7100  Vejle  
Denmark  
 
Lundbeckfond Invest A/S  
Scherfigsvej 7  
DK-2100 Copenhagen  
Denmark  
 
Arbejdsmarkedets Tillægspension  
Kongens Vænge 8  
DK-3400 Hillerød  
Denmark  
Subject : Case M.10955  – KIRK / LFI / ATP / FERROSAN MEDICAL DEVICES  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No 139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 11 November 2022 , the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger Regulation  by which Kirk Kapital 
Strategic Investments A/S (Denmark ), ultimately controlled by controlled by Kirk 
Kapital A/S  (“Kirk”, Denmark) , Lundbeckfond Invest A/S  (Denmark), ultimately  
controlled by Lundbeckfonden (Denmark) and Arbejdsmarkedets Tillægspension  
(“ATP”, Denmark) , will acquire within the meaning of Article 3(1)(b)  and 3(4)  of the 
Merg er Regulation joint control over the whole of Ferrosan Medical Devices Group 
A/S (“Ferrosan”, Denmark)  by way of purchase of shares .3 
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effe ct from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘Community ’ by ‘Union ’ and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout this decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 440, 21.11.2022 , p. 28. 

2 2. The business activities of the undertakings concerned  are the following : 
 Kirk invests in Scandinavian medium -sized and larger -sized companies in long -
term growth industries  (such as the services and light manufacturing industries) . 
Kirk also carries out financial investments, including in fixed incomes, listed 
equities and alternatives , 
 Lundbeckfonden is a Danish commercia l foundation that funds biomedical 
sciences research, focusi ng particularly on neuroscience,  
 ATP is a self -governing institution established by law to manage the mandatory 
Danish collective pension scheme, ATP Livslang Pension (Lifelong  Pension),  
 Ferrosan produces biomaterial haemostatic medical devices such as gelatin -based 
matrices, sponges and powders to control critical bleedings in surgery, as well as 
a breast biopsy system for performance of biopsies in relation to diagnosing 
breast cancer. Ferrosan m arkets its products worldwide . 
3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation  and of 
paragraph 5 (b) of the Commission Notice on a simplified procedure  for treatment of 
certain concentrations under Council Regulation (EC) No 139/2004 .4 
4. For the reasons set out in the Notice on a simplified procedure, the European 
Commission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agre ement . 
For the Commission  
 
 
(Signed)  
Olivier GUERSENT  
Director -General  
 
        
                                                 
4  OJ C 366, 14.12.2013, p. 5 .